Open AccessTreatment of Immune Thrombocytopenia With a Reversible Oral BTK Inhibitor
Author(s) -
Richard Simoneaux
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000892636.13919.d0
Subject(s) - bruton's tyrosine kinase , medicine , immune system , immune thrombocytopenia , ibrutinib , immunology , pharmacology , platelet , receptor , leukemia , tyrosine kinase , chronic lymphocytic leukemia